HSBC Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$151M Buy
3,533,722
+134,019
+4% +$7.28M 0.06% 284
2026
Q1
$213M Sell
3,399,703
-212,549
-6% -$17M 0.11% 182
2025
Q4
$345M Buy
3,612,252
+215,208
+6% +$21.1M 0.18% 100
2025
Q3
$332M Buy
3,397,044
+473,081
+16% +$49M 0.18% 88
2025
Q2
$314M Sell
2,923,963
-104,679
-3% -$10.6M 0.19% 88
2025
Q1
$305M Sell
3,028,642
-43,781
-1% -$4.41M 0.19% 93
2024
Q4
$275M Buy
3,072,423
+73,034
+2% +$6.43M 0.16% 105
2024
Q3
$251M Buy
2,999,389
+192
+0% +$15.1K 0.15% 116
2024
Q2
$231M Sell
2,999,197
-262,195
-8% -$19.2M 0.14% 123
2024
Q1
$223M Buy
3,261,392
+193,448
+6% +$12.4M 0.15% 121
2023
Q4
$177M Buy
3,067,944
+377,590
+14% +$20.2M 0.15% 116
2023
Q3
$142M Buy
2,690,354
+448,775
+20% +$23.5M 0.15% 126
2023
Q2
$121M Buy
2,241,579
+601,823
+37% +$31.4M 0.12% 151
2023
Q1
$82M Sell
1,639,756
-157,998
-9% -$7.45M 0.1% 204
2022
Q4
$83.1M Buy
1,797,754
+567,112
+46% +$24.6M 0.1% 213
2022
Q3
$48.3M Sell
1,230,642
-204,635
-14% -$8.21M 0.08% 252
2022
Q2
$54M Buy
1,435,277
+234,377
+20% +$9.54M 0.08% 255
2022
Q1
$53.6M Sell
1,200,900
-33,696
-3% -$1.46M 0.07% 292
2021
Q4
$52.9M Sell
1,234,596
-114,207
-8% -$4.8M 0.05% 368
2021
Q3
$58.9M Sell
1,348,803
-38,393
-3% -$1.7M 0.06% 295
2021
Q2
$59.5M Buy
1,387,196
+29,234
+2% +$1.23M 0.06% 293
2021
Q1
$52.8M Sell
1,357,962
-173,238
-11% -$6.56M 0.06% 312
2020
Q4
$54.6M Buy
1,531,200
+162,499
+12% +$5.86M 0.07% 268
2020
Q3
$52.3M Buy
1,368,701
+342,279
+33% +$13.2M 0.08% 217
2020
Q2
$36M Sell
1,026,422
-351,601
-26% -$12.7M 0.07% 266
2020
Q1
$44.6M Buy
1,378,023
+193,674
+16% +$7.57M 0.1% 187
2019
Q4
$53.8M Buy
1,184,349
+299,095
+34% +$12.5M 0.09% 204
2019
Q3
$36M Buy
885,254
+96,084
+12% +$4.07M 0.07% 317
2019
Q2
$33.9M Sell
789,170
-123,719
-14% -$4.76M 0.06% 314
2019
Q1
$35M Buy
912,889
+102,896
+13% +$3.93M 0.06% 307
2018
Q4
$28.6M Sell
809,993
-116,424
-13% -$4.22M 0.05% 374
2018
Q3
$35.7M Buy
926,417
+89,080
+11% +$3.11M 0.06% 346
2018
Q2
$27.4M Sell
837,337
-637,091
-43% -$19.2M 0.05% 389
2018
Q1
$40.3M Buy
1,474,428
+145,448
+11% +$3.95M 0.06% 309
2017
Q4
$32.9M Buy
1,328,980
+4,482
+0.3% +$124K 0.05% 367
2017
Q3
$38.6M Buy
1,324,498
+318,349
+32% +$8.79M 0.06% 310
2017
Q2
$27.9M Buy
1,006,149
+174,500
+21% +$4.63M 0.05% 398
2017
Q1
$20.7M Buy
831,649
+22,269
+3% +$541K 0.04% 466
2016
Q4
$17.5M Buy
809,380
+176,804
+28% +$3.86M 0.04% 514
2016
Q3
$15.1M Sell
632,576
-89,405
-12% -$2.13M 0.04% 517
2016
Q2
$16.8M Buy
721,981
+85,121
+13% +$1.84M 0.05% 470
2016
Q1
$12M Sell
636,860
-81,543
-11% -$1.43M 0.03% 575
2015
Q4
$13.3M Sell
718,403
-39,848
-5% -$714K 0.03% 581
2015
Q3
$12.4M Sell
758,251
-106,911
-12% -$1.83M 0.03% 537
2015
Q2
$15.3M Sell
865,162
-292,926
-25% -$5.23M 0.03% 502
2015
Q1
$20.6M Sell
1,158,088
-593,496
-34% -$9.38M 0.04% 434
2014
Q4
$23.2M Buy
1,751,584
+209,230
+14% +$2.67M 0.05% 404
2014
Q3
$18.2M Sell
1,542,354
-45,898
-3% -$578K 0.04% 459
2014
Q2
$20.3M Sell
1,588,252
-439,335
-22% -$5.71M 0.04% 411
2014
Q1
$27.3M Sell
2,027,587
-1,763,306
-47% -$23.1M 0.07% 313
2013
Q4
$45.6M Buy
3,790,893
+983,421
+35% +$11.6M 0.12% 183
2013
Q3
$33M Buy
2,807,472
+1,045,475
+59% +$11.3M 0.09% 246
2013
Q2
$16.3M Buy
+1,761,997
New +$14.9M 0.05% 383

Other funds holding BSX

HSBC Holdings's BSX Position: Q2 2026 in Review

HSBC Holdings increased its Boston Scientific (BSX) stake by 3.9% in Q2 2026, buying an estimated $7.28M and bringing the position to 3,533,722 shares worth $151M. The position accounts for 0.06% of the portfolio, ranked #284.

HSBC Holdings first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $345M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HSBC Holdings held 3,533,722 shares of Boston Scientific worth $151M as of Q2 2026.
  • HSBC Holdings bought 134,019 Boston Scientific shares in Q2 2026, an estimated $7.28M.
  • Boston Scientific made up 0.06% of HSBC Holdings's portfolio in Q2 2026, its #284 holding.
  • HSBC Holdings first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • HSBC Holdings's Boston Scientific position peaked at $345M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.